• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate.

作者信息

Woei-A-Jin F J Sherida H, Van Nieuwenhuyse Tine, van Erp Nielka P, Beuselinck Benoit, Stroobants Stephanie, Moes Dirk Jan A R, Osanto Susanne, Spriet Isabel

机构信息

F.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.

出版信息

J Clin Oncol. 2018 Oct 20;36(30):3062-3064. doi: 10.1200/JCO.2018.79.3182. Epub 2018 Sep 6.

DOI:10.1200/JCO.2018.79.3182
PMID:30188790
Abstract
摘要

相似文献

1
Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate.剂量降低可能危及醋酸阿比特龙的疗效。
J Clin Oncol. 2018 Oct 20;36(30):3062-3064. doi: 10.1200/JCO.2018.79.3182. Epub 2018 Sep 6.
2
Low-Dose Abiraterone With Food: Rebutting an Editorial.低剂量阿比特龙与食物同服：对一篇社论的反驳
J Clin Oncol. 2018 Oct 20;36(30):3060-3061. doi: 10.1200/JCO.2018.79.3018. Epub 2018 Sep 6.
3
Low-Dose Abiraterone Regimen: Drug Monitoring Might Be the Key.低剂量阿比特龙治疗方案：药物监测可能是关键。
J Clin Oncol. 2018 Oct 20;36(30):3061-3062. doi: 10.1200/JCO.2018.79.3174. Epub 2018 Sep 6.
4
There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive.现有令人信服的证据表明，应进一步评估低剂量醋酸阿比特龙用于转移性前列腺癌男性患者的情况：它可能更安全，或许同样有效且成本更低。
J Clin Oncol. 2018 Oct 20;36(30):3059-3060. doi: 10.1200/JCO.2018.79.3166. Epub 2018 Sep 6.
5
Low-Fat Abiraterone Food Effect Is of Great Consequence.低脂阿比特龙的食物效应至关重要。
J Clin Oncol. 2018 Oct 20;36(30):3058-3059. doi: 10.1200/JCO.2018.79.2358. Epub 2018 Sep 6.
6
Low-Fat Abiraterone Food Effect Is of Little Consequence.低脂肪阿比特龙的食物效应影响不大。
J Clin Oncol. 2018 May 10;36(14):1385-1386. doi: 10.1200/JCO.2018.78.0684. Epub 2018 Mar 28.
7
A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer.一项关于日本转移性去势抵抗性前列腺癌患者中醋酸阿比特龙序贯多西他赛治疗的多中心回顾性分析。
Jpn J Clin Oncol. 2015 Aug;45(8):774-9. doi: 10.1093/jjco/hyv070. Epub 2015 May 15.
8
Could Steroidal Abiraterone Metabolites Possibly Explain Abiraterone Withdrawal Syndrome?甾体类阿比特龙代谢产物能否解释阿比特龙撤药综合征？
Eur Urol. 2016 Nov;70(5):898-899. doi: 10.1016/j.eururo.2016.06.013. Epub 2016 Jun 20.
9
Prostate cancers that 'Wnt' respond to abiraterone.对阿比特龙有反应的前列腺癌“Wnt”。 （此译文感觉不太符合正常逻辑表达，可能原文表述有误，正常准确的可能是“对阿比特龙有反应的Wnt相关前列腺癌”之类的，但按要求严格翻译就是这样了）
Ann Oncol. 2018 Feb 1;29(2):290-292. doi: 10.1093/annonc/mdx785.
10
Re: Prostate-Specific Antigen Decline after 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer.回复：醋酸阿比特龙治疗4周后前列腺特异性抗原下降情况及转移性去势抵抗性前列腺癌患者的总生存期
J Urol. 2016 Jul;196(1):103. doi: 10.1016/j.juro.2016.04.040. Epub 2016 Apr 14.

引用本文的文献

1
Dose optimization during drug development: whether and when to optimize.药物开发过程中的剂量优化：是否以及何时进行优化。
J Natl Cancer Inst. 2023 May 8;115(5):492-497. doi: 10.1093/jnci/djac232.
2
AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis.AR-V7作为三个拉丁美洲国家阿比特龙/恩杂鲁胺治疗耐药生物标志物的假设性成本节约分析
Oncologist. 2020 Dec;25(12):e1990-e1995. doi: 10.1634/theoncologist.2020-0043. Epub 2020 Aug 19.